Research / ASAN / Fundamental state Inspectable configuration
State dimensions Filing 0001477720-21-000065 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-28.40% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
70.34% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
90.45% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-67.86% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
53.61% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
25.77% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Oct 31, 2021 0/7 normalized Level 3 Jan 31, 2022 0/7 normalized Level 3 Apr 30, 2022 0/7 normalized Level 3 Jul 31, 2022 0/7 normalized Level 3 Oct 31, 2022 4/7 normalized Level 3 Jan 31, 2023 6/7 normalized Level 3 Apr 30, 2023 6/7 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 14.07%
Current 10.71%
Delta -3.36% Cash Generation Decreased
Previous -9.52%
Current -28.40%
Delta -18.89% Margin Increased
Previous 88.97%
Current 90.45%
Delta 1.48% Profitability Decreased
Previous -67.11%
Current -67.86%
Delta -0.75% R And D Intensity Decreased
Previous 54.15%
Current 53.61%
Delta -0.54% Sbc Intensity Increased
Previous 22.78%
Current 25.77%
Delta 2.99% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.